Shield Therapeutics plc

SHIEF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$6,947-$4,377-$6,133-$8,479
Dep. & Amort.$516$308$238$94
Deferred Tax$0$0$0$0
Stock-Based Comp.$267$103$231$286
Change in WC-$2,412$988$583-$1,327
Other Non-Cash$14,592$1,779$3,668$2,364
Operating Cash Flow$6,016-$1,199-$1,413-$7,061
Investing Activities
PP&E Inv.$0-$0-$13-$25
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$833-$503-$307-$431
Investing Cash Flow-$833-$503-$321-$456
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2,865$1,244-$752$8,002
Financing Cash Flow-$2,865$1,244-$752$8,002
Forex Effect$807-$131$168-$340
Net Chg. in Cash$0-$6,407$0$145
Supplemental Information
Beg. Cash$0$6,407$10,941$0
End Cash$0$0$10,941$145
Free Cash Flow$6,016-$1,199-$1,426-$7,086
Shield Therapeutics plc (SHIEF) Financial Statements & Key Stats | AlphaPilot